Junbing He

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 6

Top Topics

Inflammatory Response

Endothelial Cells

Top Venues

Drug development research

Artificial cells, nanomedicine, and biotechnology

Mediators of inflammation

This page only lists publications with an associated author ORCID identifier.

Publications

Junbing He, Wanbing Qin, Shusong Jiang, Yao Lin, Yingying Lin, Ruoxuan Yang, Mingwei Xu, Qinghua Liu
Oxymatrine attenuates sepsis-induced inflammation and organ injury via inhibition of HMGB1/RAGE/NF-κB signaling pathway. Drug development research 85 (4) (2024)
Junbing He, Wanbing Qin, Shusong Jiang, Yao Lin, Yingying Lin, Ruoxuan Yang, Mingwei Xu, Qinghua Liu
Oxymatrine attenuates sepsis-induced inflammation and organ injury via inhibition of HMGB1/RAGE/NF-κB signaling pathway. Drug development research 85 (4) (2024)
Yao Lin, Yiming Shao, Yuchun Liu, Ruoxuan Yang, Shuanglin Liao, Shuai Yang, Mingwei Xu, Junbing He
Efficacy and safety of nafamostat mesilate anticoagulation in blood purification treatment of critically ill patients: a systematic review and meta-analysis. Renal failure 44 (1) (2022)
Kaidian Chen, Yao Lin, Yuchun Liu, Shuanglin Liao, Ruoxuan Yang, Jiefeng Huang, Mingwei Xu, Junbing He
Investigation of Association of Complement 5 Genetic Polymorphisms with Sepsis and Sepsis-Induced Inflammatory Responses. Journal of inflammation research 14 (2021)
Wenying Zhang, Furong Lu, Yuliu Xie, Yao Lin, Tian Zhao, Shoubao Tao, Zhipeng Lai, Ning Wei, Ruoxuan Yang, Yiming Shao, Junbing He
miR-23b Negatively Regulates Sepsis-Induced Inflammatory Responses by Targeting ADAM10 in Human THP-1 Monocytes. Mediators of inflammation 2019 (2019)
Yao Lin, Yiming Shao, Jieyin Li, Wenying Zhang, Kaibin Zheng, Xuying Zheng, Xiaoman Huang, Zipeng Liao, Yirui Xie, Junbing He
The hierarchical micro-/nanotextured topographies promote the proliferation and angiogenesis-related genes expression in human umbilical vein endothelial cells by initiation of Hedgehog-Gli1 signaling. Artificial cells, nanomedicine, and biotechnology 46 (sup3) (2018)